Phytochemical and Pharmacological Insight on Sesamol: An Updated Review / Namrata Singh, Poonam Kushwaha, Amresh Gupta, Om Prakash, Shivam Swarup, Shazia Usmani
Background: Nowadays, sesamol has emerged as an effective adjuvant therapeutic agent in the anticipation and therapy of various diseases. Sesamol, a natural phenolic compound is a major lignan isolated from the seeds of Sesamum indicum and sesame oil. Sesame oil is well known for its nutritional as well as their health-promoting properties. Methods: Several studies revealed that sesamol possesses significant antifungal, anti-inflammatory, antioxidant, and free radical scavenging, anticancer, neuroprotective, cardioprotective, antiaging, hepatoprotective and antidiabetic activity, etc. Results: The present review highlights the potential of sesamol as a novel medicinal agent for the treatment of numerous types of ailment. Conclusion: This review article also provides a brief idea about its uses, ethnomedicinally and commercially important analytical techniques, and its pharmacological activities.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Current bioactive compounds - 17(2021), 2, Seite 112- |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Singh, Namrata [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Umfang: |
1 Online-Ressource (8 p) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
KFL008962170 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL008962170 | ||
003 | DE-627 | ||
005 | 20231128164343.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220316s2021 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)KFL008962170 | ||
035 | |a (KFL)prod_DARH_.36EAE84574B16D5B98192011F60E963F01CD7376 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Singh, Namrata |e verfasserin |4 aut | |
245 | 1 | 0 | |a Phytochemical and Pharmacological Insight on Sesamol: An Updated Review |c Namrata Singh, Poonam Kushwaha, Amresh Gupta, Om Prakash, Shivam Swarup, Shazia Usmani |
264 | 1 | |c 2021 | |
300 | |a 1 Online-Ressource (8 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: Nowadays, sesamol has emerged as an effective adjuvant therapeutic agent in the anticipation and therapy of various diseases. Sesamol, a natural phenolic compound is a major lignan isolated from the seeds of Sesamum indicum and sesame oil. Sesame oil is well known for its nutritional as well as their health-promoting properties. Methods: Several studies revealed that sesamol possesses significant antifungal, anti-inflammatory, antioxidant, and free radical scavenging, anticancer, neuroprotective, cardioprotective, antiaging, hepatoprotective and antidiabetic activity, etc. Results: The present review highlights the potential of sesamol as a novel medicinal agent for the treatment of numerous types of ailment. Conclusion: This review article also provides a brief idea about its uses, ethnomedicinally and commercially important analytical techniques, and its pharmacological activities | ||
700 | 1 | |a Kushwaha, Poonam |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Amresh |e verfasserin |4 aut | |
700 | 1 | |a Prakash, Om |e verfasserin |4 aut | |
700 | 1 | |a Swarup, Shivam |e verfasserin |4 aut | |
700 | 1 | |a Usmani, Shazia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current bioactive compounds |d Sharjah, U.A.E. : Bentham Science Publ., 2005 |g 17(2021), 2, Seite 112- |h Online-Ressource |w (DE-627)KFL000006424 |w (DE-600)2216906-4 |w (DE-576)306832828 |x 1875-6646 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2021 |g number:2 |g pages:112- |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1573-4072&volume=17&issue=2&spage=112 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-BEJ | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
935 | |i IMPORT_0628_prod_DARH_02 | ||
951 | |a AR | ||
952 | |d 17 |j 2021 |e 2 |h 112- |